Clinical Trials Logo

Caregiver Distress clinical trials

View clinical trials related to Caregiver Distress.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04337021 Completed - Job Stress Clinical Trials

Caregiver Self-Management of Stress

Caregiver SOS
Start date: December 28, 2020
Phase: N/A
Study type: Interventional

Unpaid informal caregivers (CGs), such as family and friends, who are also employed may be at significant risk of experiencing burden and stress. This may be especially true for CGs who provide care to care recipients coping with behavioral health issues associated with conditions like depression, anxiety, post-traumatic stress disorder and traumatic brain injury. Stress not only increases the CG's risk of workplace difficulties, illness, and poor quality of life, but also impacts the CG's ability to provide care for the care recipient. The primary aim of this randomized study is to examine the impact of a novel intervention, Caregiver SOS (Self-Management of Stress), on CG distress and work performance and productivity. Caregiver SOS is delivered by phone and offers evidence-based, work and CG role performance-focused self-management counseling to employed CGs. Study findings will ultimately shed light on whether a program that specifically addresses caregiving-work balance is effective in improving CGs' wellbeing and work functioning and the quality of Veterans' care.

NCT ID: NCT04052724 Completed - Caregiver Distress Clinical Trials

Internet-based Treatment for Informal Caregivers in Lithuania LINGI

LINGI
Start date: October 3, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate efficacy of internet intervention for informal caregivers in Lithuania in reducing their care-giving burden.

NCT ID: NCT03557515 Completed - Caregiver Distress Clinical Trials

Reducing Distress in Phase 1 Trial Caregivers: The P1-CaLL Study

Start date: June 12, 2018
Phase: N/A
Study type: Interventional

This study seeks to decrease distress in the lives of the caregivers who are helping cancer patients who have entered a phase 1 clinical trial.